Alexanian R - Search Results

1

Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.

Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Wilder RB, et al. Among authors: alexanian r. Cancer. 2002 Mar 1;94(5):1532-7. doi: 10.1002/cncr.10366. Cancer. 2002. PMID: 11920511 Free article.

2

Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.

Anagnostopoulos A, Aleman A, Ayers G, Donato M, Champlin R, Weber D, Alexanian R, Giralt S. Anagnostopoulos A, et al. Among authors: alexanian r. Cancer. 2004 Jun 15;100(12):2607-12. doi: 10.1002/cncr.20294. Cancer. 2004. PMID: 15197803 Free article.

3

Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy.

Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, Arzu IY, Orlowski RZ, Thomas SK, Shihadeh F, Alexanian R, Dabaja BS. Reed V, et al. Among authors: alexanian r. Cancer. 2011 Oct 1;117(19):4468-74. doi: 10.1002/cncr.26031. Epub 2011 Mar 22. Cancer. 2011. PMID: 21437886 Free article.

4

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma.

Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R. Moulopoulos LA, et al. Among authors: alexanian r. J Clin Oncol. 1995 Jan;13(1):251-6. doi: 10.1200/JCO.1995.13.1.251. J Clin Oncol. 1995. PMID: 7799027

5

Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myeloma.

Dimopoulos MA, Weber D, Delasalle KB, Alexanian R. Dimopoulos MA, et al. Among authors: alexanian r. Cancer. 1993 Nov 1;72(9):2589-92. doi: 10.1002/1097-0142(19931101)72:9<2589::aid-cncr2820720913>3.0.co;2-#. Cancer. 1993. PMID: 8402480

6

Prognostic features of asymptomatic multiple myeloma.

Weber DM, Dimopoulos MA, Moulopoulos LA, Delasalle KB, Smith T, Alexanian R. Weber DM, et al. Among authors: alexanian r. Br J Haematol. 1997 Jun;97(4):810-4. doi: 10.1046/j.1365-2141.1997.1122939.x. Br J Haematol. 1997. PMID: 9217181 Free article.

7

Prognostic value of cytogenetics in multiple myeloma.

Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J, Huh Y, Glassman A, Champlin R, Alexanian R. Seong C, et al. Among authors: alexanian r. Br J Haematol. 1998 Apr;101(1):189-94. doi: 10.1046/j.1365-2141.1998.00657.x. Br J Haematol. 1998. PMID: 9576200 Free article.

8

Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy.

Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Liebross RH, et al. Among authors: alexanian r. Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1063-7. doi: 10.1016/s0360-3016(98)00186-2. Int J Radiat Oncol Biol Phys. 1998. PMID: 9719116

9

Clinical course of solitary extramedullary plasmacytoma.

Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Liebross RH, et al. Among authors: alexanian r. Radiother Oncol. 1999 Sep;52(3):245-9. doi: 10.1016/s0167-8140(99)00114-0. Radiother Oncol. 1999. PMID: 10580871

10

Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy.

Alexanian R, Weber D, Giralt S, Delasalle K. Alexanian R, et al. Ann Oncol. 2002 Jul;13(7):1116-9. doi: 10.1093/annonc/mdf188. Ann Oncol. 2002. PMID: 12176792 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters